Antimicrobial Drug Delivery for the Treatment of Highly Prevalent Infections
A special issue of Pathogens (ISSN 2076-0817).
Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 9381
Special Issue Editors
Interests: virology; drug delivery; sustained release; antiviral; eye; genitalia
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Microbial infections, whether bacterial or viral, can be very challenging to treat, in many cases resulting in the development of antibacterial/antiviral resistance against existing drugs. The increase in bacterial and viral resistance to standard-of-care drugs poses a serious challenge to existing treatment methodologies. In recent years, there have been multiple advances in medicinal chemistry, genomic, transcriptomic and proteomic profiling which have led to the development of novel therapeutics that target bacteria and viruses through novel modes of action previously unknown to humankind. Hence, in this Special Issue we plan to publish novel antimicrobials which show activity against resistant strains of bacteria and viruses, essentially working through previously under-appreciated modes of action. We are welcoming high-quality reviews and original research articles which address the present scenario of antimicrobial therapy against pharmaceutically important bacterial pathogens.
Dr. Tejabhiram Yadavalli
Dr. Gopinath Venkatraman
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials
- drug delivery
- antiviral resistance
- antibacterial resistance and mechanism of action
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.